4.5 Article

Comparative efficacy of HgCl2 with candidate aquaporin-1 inhibitors DMSO, gold, TEA+ and acetazolamide

期刊

FEBS LETTERS
卷 580, 期 28-29, 页码 6679-6684

出版社

WILEY
DOI: 10.1016/j.febslet.2006.11.025

关键词

AQP1; water transport; water channel; inhibitor; drug discovery

资金

  1. NEI NIH HHS [R01 EY013574, R01 EY013574-09, EY13574] Funding Source: Medline
  2. NHLBI NIH HHS [HL73856, R01 HL073856-08, R01 HL059198, R01 HL073856, HL59198, R01 HL059198-09] Funding Source: Medline
  3. NIBIB NIH HHS [R37 EB000415-18, R37 EB000415, R01 EB000415, EB00415] Funding Source: Medline
  4. NIDDK NIH HHS [R37 DK035124, R21 DK066194, DK66194, R01 DK035124, P30 DK072517, DK72517, P30 DK072517-05, R37 DK035124-22, DK35124] Funding Source: Medline

向作者/读者索取更多资源

Aquaporin-1 (AQP1) inhibitors are predicted to have multiple clinical applications. Hg++ is a non-specific and toxic AQP1 blocker. We compared compounds with reported AQP1 inhibition activity, including DMSO, An(+++), Ag+, tetraethylammonium and acetazolamide. Water permeability was measured by stopped-flow light scattering in erythrocytes and volume marker dilution in epithelial cells. Au+++ inhibited AQP1 with IC50 similar to 14 mu M, similar to 10 mu M for Hg++. DMSO slowed osmotic equilibration; however, the apparent inhibition was due to 'osmotic clamp' rather than AQP1 inhibition. Neither tetraethylammonium nor acetazolamide (to 10 mM) inhibited AQP1. Our data indicate the need to identify new AQP1 inhibitors.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据